Logo image of IPOD

SOCIAL CAPITAL HEDOSOPH- A (IPOD) Stock Fundamental Analysis

NYSE:IPOD - New York Stock Exchange, Inc. - KYG825141032 - Common Stock - Currency: USD

10.03  -0.01 (-0.1%)

After market: 10.03 0 (0%)

Fundamental Rating

2

Taking everything into account, IPOD scores 2 out of 10 in our fundamental rating. IPOD was compared to 0 industry peers in the Unkown industry. The financial health of IPOD is average, but there are quite some concerns on its profitability. IPOD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IPOD was profitable.
IPOD Yearly Net Income VS EBIT VS OCF VS FCFIPOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 6.88%
ROE 7.29%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPOD Yearly ROA, ROE, ROICIPOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 2 4 6

1.3 Margins

IPOD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPOD Yearly Profit, Operating, Gross MarginsIPOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

IPOD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, IPOD has a worse debt to assets ratio.
IPOD Yearly Shares OutstandingIPOD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M 40M 50M
IPOD Yearly Total Debt VS Total AssetsIPOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 13.42 indicates that IPOD is not in any danger for bankruptcy at the moment.
There is no outstanding debt for IPOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.42
ROIC/WACCN/A
WACCN/A
IPOD Yearly LT Debt VS Equity VS FCFIPOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.15 indicates that IPOD may have some problems paying its short term obligations.
IPOD has a Quick Ratio of 0.15. This is a bad value and indicates that IPOD is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
IPOD Yearly Current Assets VS Current LiabilitesIPOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.47% over the past year.
EPS 1Y (TTM)83.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7808.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPOD Yearly Revenue VS EstimatesIPOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021
IPOD Yearly EPS VS EstimatesIPOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.24, which indicates a rather expensive current valuation of IPOD.
Compared to an average S&P500 Price/Earnings ratio of 29.62, IPOD is valued a bit cheaper.
Industry RankSector Rank
PE 18.24
Fwd PE N/A
IPOD Price Earnings VS Forward Price EarningsIPOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPOD Per share dataIPOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IPOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOCIAL CAPITAL HEDOSOPH- A

NYSE:IPOD (10/14/2022, 8:04:00 PM)

After market: 10.03 0 (0%)

10.03

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.73%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap576.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.24
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.55
EY5.48%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.56
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.88%
ROE 7.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z 13.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7808.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A